Activity and penetration of antituberculosis drugs in mouse peritoneal macrophages infected with Mycobacterium microti OV254
Open Access
- 1 August 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (8), 1255-1259
- https://doi.org/10.1128/aac.33.8.1255
Abstract
The activities of some commonly used antituberculosis drugs were investigated within unstimulated peritoneal macrophages and in 7H-9 medium without Tween 80 using Mycobacterium microti OV254 as the target organism. In macrophage cultures, serial concentrations of isoniazid, rifampin, pyrazinamide, or streptomycin were added after a 2.5-h phagocytosis period. Viable counts were carried out at daily intervals for 5 or 6 days. The patterns of susceptibility to the four drugs were similar for M. microti and Mycobacterium tuberculosis. To ensure comparability with daily drug replacements in the macrophage experiments, the period of exposure to drugs in 7H-9 medium was kept to only 3 days. With in vitro culture at pH 6.4, drug penetration, measured as the ratio of MICs in macrophages to MICs in 7H-9 medium, was approximately 5 for isoniazid, 5 for rifampin, and 10 for streptomycin. With in vitro culture at pH 7.4, drug penetration was 100 for streptomycin, and at pH 5.6 it was 1 for pyrazinamide. Pyrazinamide was only bacteriostatic in macrophages but weakly bactericidal during the first day of exposure in vitro.This publication has 25 references indexed in Scilit:
- Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophagesTubercle, 1988
- The action of antituberculosis drugs in short-course chemotherapyTubercle, 1985
- Interactions of antibiotics and phagocytesJournal of Antimicrobial Chemotherapy, 1983
- Killing of Mycobacterium microti by immunologically activated macrophagesNature, 1981
- Phagosome-Lysosome Fusion and Cyclic Adenosine 3': 5'-Monophosphate in Macrophages Infected with Mycobacterium microti, Mycobacterium bovis BCG or Mycobacterium lepraemuriumJournal of General Microbiology, 1979
- BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life.BMJ, 1977
- Plasma and salivary concentrations of isoniazid in man: Preliminary findings in two slow acetylator subjectsJournal of Pharmacokinetics and Biopharmaceutics, 1975
- Mycobacterium microti may protect itself from intracellular destruction by releasing cyclic AMP into phagosomesNature, 1975
- Binding of rifampicin by human plasma proteinsEuropean Journal of Clinical Pharmacology, 1974
- TITRATION OF STRAINS OF TUBERCLE BACILLI AGAINST ISONIAZIDThe Lancet, 1952